Brief: Telomir Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
08/06/2026 22:16
BRIEF-Telomir Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing June 8 (Reuters) - Telomir Pharmaceuticals Inc TELO.O:
TELOMIR PHARMACEUTICALS - ALAN WEICHSELBAUM TO STEP DOWN AS CFO EFFECTIVE JUNE 6, 2026 - SEC FILING
TELOMIR PHARMACEUTICALS - APPOINTS ANDRIY MUSHAK AS FRACTIONAL CFO EFFECTIVE JUNE 6, 2026 - SEC FILING
Source text: [ID:n0001493152-26-027752]
Further company coverage: TELO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telomir Pharmaceuticals
See all newsBrief: Telomir Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality In Human Triple-Negative Breast Cancer Models
Brief: Telomir Pharmaceuticals Telomir-1 Significantly Reduced Tumor Growth And Metastases
Brief: Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’S “Kill-And-Clean” Defense Systems In An Aggressive Prostate Cancer Model
U.S. STOCKS ON THE MOVE-InterDigital, Scholar Rock, Live Nation